FFA
LLY icon

Founders Financial Alliance’s Eli Lilly LLY Stock Holding History

Founders Financial Alliance’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Buy
1,993
+242
+14% +$247K 0.32% 75
2026
Q1 		$1.61M Sell
1,751
-8
-0.5% -$8.11K 0.29% 84
2025
Q4 		$1.89M Buy
1,759
+5
+0.3% +$4.78K 0.36% 65
2025
Q3 		$1.34M Sell
1,754
-125
-7% -$93K 0.25% 93
2025
Q2 		$1.46M Sell
1,879
-31
-2% -$24.1K 0.33% 71
2025
Q1 		$1.58M Buy
1,910
+333
+21% +$277K 0.38% 57
2024
Q4 		$1.22M Sell
1,577
-309
-16% -$256K 0.33% 66
2024
Q3 		$1.67M Sell
1,886
-240
-11% -$216K 0.47% 46
2024
Q2 		$1.93M Sell
2,126
-1
-0% -$800 0.57% 38
2024
Q1 		$1.65M Buy
2,127
+70
+3% +$49.8K 0.5% 43
2023
Q4 		$1.2M Sell
2,057
-687
-25% -$401K 0.46% 44
2023
Q3 		$1.47M Sell
2,744
-173
-6% -$89.1K 0.64% 32
2023
Q2 		$1.37M Buy
2,917
+189
+7% +$79.3K 0.54% 40
2023
Q1 		$936K Buy
2,728
+92
+3% +$31K 0.47% 55
2022
Q4 		$964K Buy
2,636
+251
+11% +$89K 0.44% 59
2022
Q3 		$771K Sell
2,385
-197
-8% -$62.4K 0.39% 67
2022
Q2 		$837K Buy
2,582
+192
+8% +$57.6K 0.42% 63
2022
Q1 		$685K Buy
2,390
+26
+1% +$6.69K 0.3% 78
2021
Q4 		$653K Buy
2,364
+35
+2% +$8.87K 0.26% 87
2021
Q3 		$538K Sell
2,329
-60
-3% -$14.8K 0.25% 93
2021
Q2 		$551K Buy
2,389
+117
+5% +$23.5K 0.25% 93
2021
Q1 		$442K Buy
2,272
+119
+6% +$23.3K 0.22% 105
2020
Q4 		$364K Buy
2,153
+63
+3% +$9.41K 0.21% 112
2020
Q3 		$306K Buy
+2,090
New +$323K 0.18% 114

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Founders Financial Alliance's LLY Position: Q2 2026 in Review

Founders Financial Alliance increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $247K and bringing the position to 1,993 shares worth $2.39M. The position accounts for 0.32% of the portfolio, ranked #75.

Founders Financial Alliance first reported a position in LLY in Q3 2020 and has held it in 24 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Founders Financial Alliance held 1,993 shares of Eli Lilly worth $2.39M as of Q2 2026.
  • Founders Financial Alliance bought 242 Eli Lilly shares in Q2 2026, an estimated $247K.
  • Eli Lilly made up 0.32% of Founders Financial Alliance's portfolio in Q2 2026, its #75 holding.
  • Founders Financial Alliance first reported a position in Eli Lilly in Q3 2020 and has held it in 24 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Founders Financial Alliance's 13F filing for Q2 2026, filed 4 Aug 2026.